Top compounds associated with response to CD79B


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.044 0.4
mRNA tivozanib CTRPv2 pan-cancer AAC -0.047 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.0079 0.8
mRNA tosedostat CTRPv2 pan-cancer AAC 0.047 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.019 0.6
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.013 0.8
mRNA triptolide CTRPv2 pan-cancer AAC -0.072 0.06
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.2 7e-08
Download CSV